Clinical Trial

Hearing Outcomes With the Osia 3 Sound Processor Compared to the Osia 2 Sound Processor in Adult Osia Implant Recipients

Study acronym: SONUS
Completed
View on ClinicalTrials.gov →
Summary
The goal of this interventional study is to evaluate the clinical performance and sound quality of the Osia 3 Sound Processor and to demonstrate its superiority compared with the Osia 2 Sound Processor in adults with mixed hearing loss, conductive hearing loss, or single-sided deafness. The main questions this study aims to answer are: * Do the findings confirm the clinical performance of the Osia 3 Sound Processor? * Is the Osia 3 Sound Processor superior compared to the Osia 2 Sound Processor? Participants will: * Undergo speech performance testing in both quiet and noisy environments * Provide ratings for a self-reported questionnaire
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-02; most recent amendment 2026-01-07.
Status change: Recruiting → Completed 2026-01-07
Status change: Not Yet Recruiting → Recruiting 2025-09-18
Trial Details
NCT Number NCT07156461
Lead Sponsor Cochlear
Collaborators: Avania
Conditions Hearing Loss, Mixed, Hearing Loss, Conductive, Single-Sided Deafness, Bone Conduction
Enrollment 29 participants
Start Date 2025-09-09
Primary Completion 2025-11-24 (estimated)
Study Completion 2025-11-24 (estimated)
Updated on ClinicalTrials.gov 2026-01-08